Literature DB >> 8570516

Optimization of lyophilization conditions for recombinant human interleukin-2 by dried-state conformational analysis using Fourier-transform infrared spectroscopy.

S J Prestrelski1, K A Pikal, T Arakawa.   

Abstract

PURPOSE: Examination of the dried-state conformation of interleukin-2 (IL-2) was used to determine the pH conditions and stabilizers that provide optimal storage stability for the lyophilized product.
METHODS: Fourier-transform infrared spectroscopy and accelerated stability studies which examined solubility, aggregate formation, and covalent cross-linking were used.
RESULTS: Varying the pH in the absence of excipients resulted in dramatic differences in the dried state conformation of IL-2. At pH 7, IL-2 unfolds extensively upon lyophilization while at pH below 5 it remains essentially native. Additional unfolding was observed upon incubation at elevated temperatures. A strong direct correlation between the retention of the native (aqueous) structure during freeze-drying and enhanced stability is demonstrated. IL-2 prepared at pH 5 is approximately an order of magnitude more stable than at pH 7 with regard to formation of soluble and insoluble aggregates. A similar pH profile was observed in the presence of excipients, although the excipients alter the overall stability profile. Additional accelerated stability studies examined the stabilizers necessary for optimal stability.
CONCLUSIONS: Excipients with the capacity to substitute for water upon dehydration better preserve the native structure resulting in enhanced stability. Those that have high glass transition temperatures provide the highest level of stability during storage, although they do not prevent dehydration induced unfolding.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8570516     DOI: 10.1023/a:1016296801447

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  12 in total

1.  Research and development of phamaceutical dosage forms.

Authors:  P P DeLuca
Journal:  Dev Biol Stand       Date:  1976-10

2.  Development of a lyophilized formulation of interleukin-2.

Authors:  M S Hora; R K Rana; C L Wilcox; N V Katre; P Hirtzer; S N Wolfe; J W Thomson
Journal:  Dev Biol Stand       Date:  1992

3.  Dehydration-induced conformational transitions in proteins and their inhibition by stabilizers.

Authors:  S J Prestrelski; N Tedeschi; T Arakawa; J F Carpenter
Journal:  Biophys J       Date:  1993-08       Impact factor: 4.033

4.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

5.  Long-term stabilization of biologicals.

Authors:  F Franks
Journal:  Biotechnology (N Y)       Date:  1994-03

6.  Protein structure by Fourier transform infrared spectroscopy: second derivative spectra.

Authors:  H Susi; D M Byler
Journal:  Biochem Biophys Res Commun       Date:  1983-08-30       Impact factor: 3.575

7.  Effect of secondary structure on the rate of deamidation of several growth hormone releasing factor analogs.

Authors:  C L Stevenson; A R Friedman; T M Kubiak; M E Donlan; R T Borchardt
Journal:  Int J Pept Protein Res       Date:  1993-12

8.  Three-dimensional structure of interleukin-2.

Authors:  B J Brandhuber; T Boone; W C Kenney; D B McKay
Journal:  Science       Date:  1987-12-18       Impact factor: 47.728

9.  Separation of freezing- and drying-induced denaturation of lyophilized proteins using stress-specific stabilization. II. Structural studies using infrared spectroscopy.

Authors:  S J Prestrelski; T Arakawa; J F Carpenter
Journal:  Arch Biochem Biophys       Date:  1993-06       Impact factor: 4.013

10.  Separation of freezing- and drying-induced denaturation of lyophilized proteins using stress-specific stabilization. I. Enzyme activity and calorimetric studies.

Authors:  J F Carpenter; S J Prestrelski; T Arakawa
Journal:  Arch Biochem Biophys       Date:  1993-06       Impact factor: 4.013

View more
  21 in total

1.  X-ray crystal structures of a severely desiccated protein.

Authors:  J A Bell
Journal:  Protein Sci       Date:  1999-10       Impact factor: 6.725

2.  Evaluation of the information content in infrared spectra for protein secondary structure determination.

Authors:  Erik Goormaghtigh; Jean-Marie Ruysschaert; Vincent Raussens
Journal:  Biophys J       Date:  2006-01-20       Impact factor: 4.033

3.  FTIR and nDSC as analytical tools for high-concentration protein formulations.

Authors:  Susanne Matheus; Wolfgang Friess; Hanns-Christian Mahler
Journal:  Pharm Res       Date:  2006-05-26       Impact factor: 4.200

4.  Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on Stability II: stability of a vaccine.

Authors:  Ahmad M Abdul-Fattah; Vu Truong-Le; Luisa Yee; Emilie Pan; Yi Ao; Devendra S Kalonia; Michael J Pikal
Journal:  Pharm Res       Date:  2007-02-15       Impact factor: 4.200

Review 5.  Stability of protein pharmaceuticals: an update.

Authors:  Mark Cornell Manning; Danny K Chou; Brian M Murphy; Robert W Payne; Derrick S Katayama
Journal:  Pharm Res       Date:  2010-02-09       Impact factor: 4.200

6.  The stability of insulin in crystalline and amorphous solids: observation of greater stability for the amorphous form.

Authors:  M J Pikal; D R Rigsbee
Journal:  Pharm Res       Date:  1997-10       Impact factor: 4.200

Review 7.  Rational design of stable lyophilized protein formulations: some practical advice.

Authors:  J F Carpenter; M J Pikal; B S Chang; T W Randolph
Journal:  Pharm Res       Date:  1997-08       Impact factor: 4.200

8.  Effect of pH and excipients on structure, dynamics, and long-term stability of a model IgG1 monoclonal antibody upon freeze-drying.

Authors:  Jihea Park; Karthik Nagapudi; Camille Vergara; Ranjini Ramachander; Jennifer S Laurence; Sampathkumar Krishnan
Journal:  Pharm Res       Date:  2012-11-27       Impact factor: 4.200

9.  Disaccharides Protect Antigens from Drying-Induced Damage in Routinely Processed Tissue Sections.

Authors:  Giovanna Boi; Carla Rossana Scalia; Rossella Gendusa; Susanna Ronchi; Giorgio Cattoretti
Journal:  J Histochem Cytochem       Date:  2015-10-20       Impact factor: 2.479

10.  The effect of formulation excipients on protein stability and aerosol performance of spray-dried powders of a recombinant humanized anti-IgE monoclonal antibody.

Authors:  J D Andya; Y F Maa; H R Costantino; P A Nguyen; N Dasovich; T D Sweeney; C C Hsu; S J Shire
Journal:  Pharm Res       Date:  1999-03       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.